Doctor profile · Federal record
Dr. MUKHTAR SHAH, M.D.
Psychiatry Physician (CMS: PSYCHIATRY) · WICHITA, KS
- NPI 1396763827
- Accepts Medicare
- 63 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1148 S. HILLSIDE ST, SUITE 104
WICHITA, KS 672114006
(316) 687-0006
fax (316) 687-0328 - Mailing address
-
1148 S HILLSIDE ST, SUITE 104
WICHITA, KS 672114006
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- January 27, 2017
- Year of graduation
- 1963 — 63 yrs since
- Specialty taxonomy
- 2084P0800X — NUCC code
- State license (1)
- Kansas #04-17352
- Medicaid
- KS #100089090E
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1396763827. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
690
Distinct HCPCS
4
Medicare allowed
$56,630
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 440 | 121 | $82 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 213 | 15 | $69 | |
90792 |
Psychiatric diagnostic evaluation with medical services | 20 | 20 | $186 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 17 | 13 | $117 |
In context: peer comparison
Among 19 peers in this city , average services per provider: 111. This provider delivers 6.2× the peer median.Open Payments
Industry payments received
All-time total
$1,301
Transactions
67
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lundbeck LLC | 10 | $239.70 | |
| Vanda Pharmaceuticals Inc. | 8 | $198.28 | |
| Teva Pharmaceuticals USA, Inc. | 9 | $168.76 | |
| Neurocrine Biosciences, Inc. | 13 | $140.29 | |
| Axsome Therapeutics, Inc. | 4 | $106.45 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82.78 | |
| IDORSIA PHARMACEUTICALS US INC | 4 | $69.52 | |
| Alkermes, Inc. | 3 | $61.49 | |
| Otsuka America Pharmaceutical, Inc. | 3 | $58.59 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50.05 | |
| IRONSHORE PHARMACEUTICALS INC. | 2 | $46.74 | |
| Corium, LLC | 1 | $24.41 | |
| Bausch Health US, LLC | 1 | $23.46 | |
| Neos Therapeutics, LP | 1 | $15.66 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $15.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,009
Patients
305
Total drug cost
$26,045
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Alprazolam | Generic | 269 | 34 | $2,319 |
| Quetiapine Fumarate | Generic | 209 | 33 | $3,328 |
| Trazodone Hcl | Generic | 204 | 33 | $1,917 |
| Sertraline Hcl | Generic | 190 | 28 | $1,302 |
| Venlafaxine Hcl Er (Venlafaxine Hcl) | Brand | 161 | 25 | $2,451 |
| Lamotrigine | Generic | 145 | 26 | $1,702 |
| Clonazepam | Generic | 133 | 17 | $1,483 |
| Bupropion Xl (Bupropion Hcl) | Brand | 113 | 18 | $2,450 |
| Lorazepam | Generic | 106 | 16 | $899 |
| Duloxetine Hcl | Generic | 103 | 18 | $1,880 |